{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:50:09Z","timestamp":1772527809613,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:title>Purpose<\/jats:title>\n          <jats:p>Tumor-induced osteomalacia (TIO) is a chronic, devastating disease. The causative tumor is usually a small benign one that is very difficult to localize. Because the presenting symptoms include diffuse bone pain, a bone scintigraphy is commonly performed to determine the cause of the pain before TIO is suspected. In this retrospective investigation, we tried to assess whether bone scintigraphy acquired will be helpful in the eventual identification of the culprit tumor.<\/jats:p>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The images of bone scan and clinical charts of total 91 patients with confirmed TIO were retrospectively reviewed. The image findings were compared with the results of other imaging studies, surgical notes, histopathologic examinations and clinical follow-ups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In 76.9% (70 of 91) of the patients, the findings of bone scintigraphy did not correspond to the sites of the causative tumors, which were subsequently located. However, in 23.1% of the patients (21 of 91), the sites of the causative tumors corresponded to one of the abnormal technetium 99m-methyl diphosphonate activity on bone scintigraphy. More importantly, 6 tumors corresponded to the dominant activity on bone scintigraphy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Although findings of whole-body scintigraphy are nonspecific in patients with TIO, careful evaluation of bone scintigraphy results can be helpful in guiding further evaluation in some patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002012","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T18:37:37Z","timestamp":1519238257000},"page":"239-245","source":"Crossref","is-referenced-by-count":8,"title":["The Findings on Bone Scintigraphy in Patients With Suspected Tumor-Induced Osteomalacia Should Not Be Overlooked"],"prefix":"10.1097","volume":"43","author":[{"given":"Ling","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bonr.2017.09.002","article-title":"Tumor-induced osteomalacia","volume":"7","year":"2017","journal-title":"Bone Rep"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumour-induced osteomalacia","volume":"3","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"bib4-20230925","first-page":"512","article-title":"Tumor-induced osteomalacia: an up-to-date review","volume":"17","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1066896915617828","article-title":"FGF23-associated tumor-induced osteomalacia in a patient with small cell carcinoma: a case report and regulatory mechanism study","volume":"24","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1210\/jc.2014-2120","article-title":"Ovarian cancer\u2013related hypophosphatemic osteomalacia\u2014a case report","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/RLU.0b013e3182a20ded","article-title":"Osteomalacia-inducing renal clear cell carcinoma uncovered by 99mTc-hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) scintigraphy","volume":"38","year":"2013","journal-title":"Clin Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bonr.2015.11.004","article-title":"Tumor induced osteomalacia secondary to anaplastic thyroid carcinoma: a case report and review of the literature","volume":"5","year":"2016","journal-title":"Bone Rep"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1007\/s11999-013-3178-1","article-title":"The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?","volume":"471","year":"2013","journal-title":"Clin Orthop Relat Res"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.clinbiochem.2011.07.013","article-title":"Tumor-induced osteomalacia: the tumor may stay hidden!","volume":"44","year":"2011","journal-title":"Clin Biochem"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/RHU.0b013e3181960483","article-title":"Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery","volume":"15","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2013-2528","article-title":"Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000890","article-title":"Phosphaturic mesenchymal tumors: clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum","volume":"41","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ejrad.2013.04.006","article-title":"Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan","volume":"82","year":"2013","journal-title":"Eur J Radiol"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/RLU.0000000000000854","article-title":"68Ga DOTATATE PET\/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib16-20230925","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","article-title":"68Ga-DOTATATE for tumor localization in tumor-induced osteomalacia","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/RLU.0b013e3182996293","article-title":"99mTc-HYNIC-TOC (99mTc-hydrazinonicotinyl-Tyr3-octreotide) scintigraphy identifying two separate causative tumors in a patient with tumor-induced osteomalacia (TIO)","volume":"38","year":"2013","journal-title":"Clin Nucl Med"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2967\/jnmt.113.126763","article-title":"Evaluation of tumor-induced osteomalacia with 111In-pentetreotide scintigraphy","volume":"41","year":"2013","journal-title":"J Nucl Med Technol"},{"key":"bib19-20230925","first-page":"247","article-title":"Bone scan in tumor-induced osteomalacia","volume":"36","year":"1995","journal-title":"J Nucl Med"},{"key":"bib20-20230925","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/RLU.0b013e3180a1ad1d","article-title":"Tumor-induced osteomalacia: a case of diagnostic dilemma","volume":"32","year":"2007","journal-title":"Clin Nucl Med"},{"key":"bib21-20230925","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0972-3919.119541","article-title":"Bone scintigraphic patterns in patients of tumor induced osteomalacia","volume":"28","year":"2013","journal-title":"Indian J Nucl Med"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1681\/ASN.2007020143","article-title":"Hypophosphatemia: clinical consequences and management","volume":"18","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/fon-2017-0393","article-title":"The utility of 68Ga-DOTATATE positron-emission tomography\/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors","volume":"14","year":"2018","journal-title":"Future Oncol"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/RLU.0000000000001674","article-title":"Comparison of the 68Ga-DOTATATA PET\/CT, FDG PET\/CT, and MIBG SPECT\/CT in the evaluation of suspected primary pheochromocytomas and paragangliomas","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RLU.0000000000001424","article-title":"PET\/CT With 68Ga-DOTA-TATE for diagnosis of neuroendocrine: differentiation in patients with castrate-resistant prostate cancer","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib26-20230925","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2967\/jnumed.114.148247","article-title":"Impact of 68Ga-DOTATATE PET\/CT on the management of neuroendocrine tumors: the referring physician's perspective","volume":"56","year":"2015","journal-title":"J Nucl Med"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/RLU.0000000000001100","article-title":"Spectrum of 68Ga-DOTA TATE uptake in patients with neuroendocrine tumors","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib28-20230925","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1532-5415.1981.tb02395.x","article-title":"Isotopic scanning of bone in the diagnosis of osteomalacia","volume":"29","year":"1981","journal-title":"J Am Geriatr Soc"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/RLU.0000000000001343","article-title":"Serendipitous detection of Hodgkin lymphoma by 18F-NaF PET\/CT","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib30-20230925","first-page":"528","article-title":"Intense uptake of technetium-99m-MDP in primary breast adenocarcinoma with sarcomatoid metaplasia","volume":"38","year":"1997","journal-title":"J Nucl Med"},{"key":"bib31-20230925","first-page":"362","article-title":"Unusual extraosseous tumoral accumulation of 99mTc-MDP","volume":"10","year":"1985","journal-title":"Eur J Nucl Med"},{"key":"bib32-20230925","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/RLU.0000000000001136","article-title":"Massive Pelvic Lymphadenopathy due to recurrent non-Hodgkin lymphoma incidentally revealed on a 99mTc-MDP bone scintigraphy","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib33-20230925","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/RLU.0000000000001473","article-title":"99mTc-MDP uptake in diffuse pleural recurrences of pulmonary neuroendocrine carcinoma","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib34-20230925","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/RLU.0000000000000394","article-title":"A large pelvic soft tissue mass implied by subtle bone scan findings","volume":"39","year":"2014","journal-title":"Clin Nucl Med"},{"key":"bib35-20230925","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00003072-200208000-00007","article-title":"Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report","volume":"27","year":"2002","journal-title":"Clin Nucl Med"},{"key":"bib36-20230925","first-page":"493","article-title":"A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan","volume":"21","year":"2003","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201804000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:01:25Z","timestamp":1695618085000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201804000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002012","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}